Welcome, A.J. Noronha

This profile has not been claimed and data may not be accurate.

Founder10

1st percentile

Investor46

81st percentile

Combined56
First-Time FounderAngel Investor

Investor Matrix

Credibility

Portfolio 82Exits 44Firm 89Experience 37Capital 49
this founder typical investor (50th pct)

Firm Standing · 89th percentile

  • General Partner and Managing Director at GX Ventures, an active venture capital fund.
  • Venture Partner at Erez Capital, adding another active investing role.

Founder score

  • 82%Probability of being accurate (82%)Past co-founder and acting CEO of Citrics Biomedical, a biotechnology startup focused on nanocomposite-based tissue regeneration.
  • 80%Probability of being accurate (80%)Citrics Biomedical had co-founders, confirming a co-founded venture.

Investor score

What you likely need

A.J. is a hybrid investor-operator with deep VC and equity research experience across multiple firms, but his public profile is fragmented across many concurrent roles, which may dilute his credibility with LPs and founders. His strongest near-term opportunity is consolidating his narrative around GX Ventures and actively seeking LP commitments for a formal fund close.

Are these your current priorities?

We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.

  • positioningConsolidate your public identity around one primary fund or firm (GX Ventures) to reduce confusion from your many concurrent roles and make it easier for LPs and founders to understand your focus.
  • fundraisingLeverage your Startup Legends podcast appearance and MOI Global article as credibility anchors when reaching out to family offices and HNW individuals as LP prospects for GX Ventures.
  • positioningDocument and publish your angel investment track record (even anonymized outcomes) to build a verifiable signal for LPs evaluating your fund management capabilities.
  • introsEngage the YC alumni network through Bookface or YC events to source early-stage deal flow aligned with your ESG and cross-border focus areas.
  • positioningRepublish or update your SumZero top-ranked equity research publicly to reinforce your public markets credibility alongside your VC narrative.
  • tacticalUse your Market Partner role at Cirrus Capital Partners to source deal flow from startups seeking capital, creating a pipeline for GX Ventures investments.
  • positioningLean into your Citrics Biomedical co-founder experience when pitching to life-science or deep-tech founders — founder-to-founder credibility is a differentiator for early-stage investors.